Some evidence suggests that, in certain individuals with HIV-1 infection, proviral activation of STAT3—and in some cases, both STAT3 and LCK—may compensate for one or more steps required for the development of T-cell lymphomas. Here, STAT3 is linked to T-cell non-Hodgkin lymphoma.